Covered recipient · General Payments record
JAMES COLEMAN GREEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2024
$282.42
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $282.42 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $53.48 | 3 |
| Lilly USA, LLC | $46.36 | 3 |
| Acerta Pharma LLC | $45.92 | 2 |
| PFIZER INC. | $45.67 | 3 |
| SHIELD THERAPEUTICS INC | $41.07 | 3 |
| Novo Nordisk AS | $19.76 | 1 |
| GlaxoSmithKline, LLC. | $15.36 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $282.42 | 17 |
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.49 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832908 | CMS |
| ABBVIE INC. | $19.06 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832910 | CMS |
| ABBVIE INC. | $14.93 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103832912 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.40 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105806226 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.52 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105747733 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.80 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086135021 | CMS |
| GlaxoSmithKline, LLC. | $15.36 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116419076 | CMS |
| Lilly USA, LLC | $13.32 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135044198 | CMS |
| Lilly USA, LLC | $16.31 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135020392 | CMS |
| Lilly USA, LLC | $16.73 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135044200 | CMS |
| Novo Nordisk Inc | $19.76 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096990146 | CMS |
| PFIZER INC. | $14.25 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132034364 | CMS |
| PFIZER INC. | $14.01 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132115125 | CMS |
| PFIZER INC. | $17.41 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130882100 | CMS |
| SHIELD THERAPEUTICS INC | $14.45 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150146402 | CMS |
| SHIELD THERAPEUTICS INC | $13.09 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150150867 | CMS |
| SHIELD THERAPEUTICS INC | $13.53 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150156355 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.